Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia

NCT00142181

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Beth Isreal Deaconness Medical Center Boston, Massachusetts, United States

Dana-farber Cancer Insitiute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00004002

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation

NCT00003143

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Completed

Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

NCT00093769

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

NCT00255749

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +64 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

NCT00296023

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +64 more
Locations: Alta Bates Comprehensive Cancer Center Berkeley, California, United States

UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

NCT00787761

Conditions: Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
Locations: Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

View Trial Details

Completed

Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)

NCT01054781

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)

NCT00005626

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma

NCT00079261

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +14 more
Locations: U.Z. Gasthuisberg Leuven, Belgium

Algemeen Ziekenhuis Sint-Augustinus Wilrijk, Belgium

University Hospital Rebro Zagreb, Croatia

National Cancer Institute - Cairo Cairo, Egypt

View Trial Details

Lymphoma, B-Cell

Lymphoma, B-Cell trial results

Related conditions